Diseases of the Nervous System, Phase II-III
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
Volunteers
Health Professionals
What is the purpose of this trial?
The proposed study is relevant to public health because narrowing of brain arteries is one of the most common causes of stroke worldwide. Compelling evidence suggests novel antithrombotic medications could reduce the rate of stroke in patients with narrowed brain arteries. The proposed study will directly compare novel antithrombotic medications to standard care antiplatelet medications for preventing stroke and death from vascular causes in patients with narrowed brain arteries.
- Trial withNational Institute of Neurological Disorders and Stroke (NINDS)
- Ages30 years - 80 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Adam de Havenon, MD, MSCI
- Adam Jasne, MD
- Adeel Zubair, MD
- Caitlin Loomis, MD
- Joseph Schindler, MD
- Lauren Hachmann Sansing, MD, MS, FAHA, FANA
- N. Abimbola Sunmonu, MD/PhD
- Necolle Morgado-Vega, DO
- Nils Petersen, MD/PhD, MSc
- Nishant Kumar Mishra, MD, PhD, FRCP, FAHA
- Rachel Forman, MD
- Reshma Narula, MD
- Richa Sharma, MD, MPH
- Last Updated07/02/2024
- Study HIC#2000031893